AliMed

Based in the US, AliMed operates as a medical supply company specializing in a broad range of products aimed at enhancing patient care and improving health outcomes across various healthcare settings. Founded in 1970 by Barbara and Julian Cherubini, AliMed is a medical supply company located in Dedham, US, providing essential products to healthcare providers. The company underwent an acquisition by Hammond, Kennedy, Whitney & Co. in August 2025, facilitating its growth strategy.

AliMed specializes in a comprehensive range of medical products and supplies designed to enhance patient care and improve health outcomes. Their core offerings include durable medical equipment, foot care and therapy products, wound and skin care supplies, and a diverse array of ergonomic furniture and accessories. The company provides solutions that address specific needs in healthcare settings, focusing on relieving pain, supporting mobility, and ensuring patient safety. Their products are utilized by healthcare professionals across various sectors, including clinics, home care environments, and emergency services.

AliMed serves a global market, distributing products to North America, Europe, and Asia, effectively addressing the needs of healthcare providers and end-users seeking innovative solutions for medical challenges. AliMed generates revenue through direct sales of its medical products, targeting healthcare providers, hospitals, clinics, and home care agencies. The company employs a straightforward transaction structure, where clients can purchase products on a one-time basis or via bulk orders, often benefiting from volume discounts. Their pricing strategy includes individual products such as the DARCO® PegAssist™ offloading insole system and the AliMed® FREEDOM® orthotic devices, priced to reflect their specialized nature and professional application.

By catering to a B2B model, AliMed ensures that healthcare organizations have reliable access to essential medical supplies while fostering long-term relationships with various clients through streamlined ordering processes. In August 2025, Hammond, Kennedy, Whitney & Co. acquired AliMed. This acquisition is expected to enable AliMed to accelerate its growth.

The company plans to introduce new products designed to meet the evolving needs of healthcare providers and expand its market presence in North America, Europe, and Asia.